440 Participants Needed

Pain Communication Toolkit for Caregivers of Alzheimer's Patients

(PICT Trial)

LB
LM
LS
Overseen ByLisa Sacerio
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Weill Medical College of Cornell University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a toolkit designed to help caregivers of individuals with Alzheimer's and similar conditions identify and communicate about pain. The Pain Identification and Communication Toolkit includes training on recognizing pain, coaching on effective communication with doctors, and planning for managing pain symptoms. It aims to improve how caregivers handle pain-related issues for those they care for. Caregivers who visit someone with dementia and a pain diagnosis at least once a week, and are not paid for their caregiving, might be suitable for this trial. As an unphased study, this trial offers caregivers the chance to enhance their skills and improve the quality of care they provide.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What prior data suggests that the Pain Identification and Communication Toolkit is safe for caregivers of Alzheimer's patients?

Research has shown that the Pain Identification and Communication Toolkit (PICT) helps caregivers recognize and discuss pain in individuals with Alzheimer's and similar conditions. PICT is not a medicine or medical procedure; it is a training program with various components. Caregivers learn to identify signs of pain and how to communicate these with doctors. They also receive guidance on responding when they notice pain.

As PICT is a training program rather than a medical treatment, no reports of side effects like those seen in drug trials exist. The program focuses on enhancing caregivers' skills, so the safety concerns typical of drug treatments do not apply. This makes it a low-risk option for those considering participation.12345

Why are researchers excited about this trial?

Researchers are excited about the Pain Identification and Communication Toolkit (PICT) because it addresses a critical gap in Alzheimer's care: effectively identifying and communicating pain. While standard care often relies on medications or behavioral interventions, PICT empowers caregivers with tools to spot pain in non-verbal patients using an observational assessment tool. It also equips caregivers with strategies to communicate effectively with healthcare providers and includes ongoing coaching to enhance caregiver skills. This approach not only aims to improve patient comfort but also supports caregivers in making informed decisions, potentially transforming pain management for Alzheimer's patients.

What evidence suggests that the Pain Identification and Communication Toolkit is effective for caregivers of Alzheimer's patients?

Research has shown that up to 60% of older adults with Alzheimer's and similar conditions experience significant pain, which often goes unnoticed and untreated. In this trial, caregivers will join one of two groups. One group will use the Pain Identification and Communication Toolkit (PICT), which studies have shown helps caregivers better notice and report pain in these patients. PICT provides training on spotting signs of pain and effectively communicating these signs to healthcare providers. Early trials suggested that caregivers using PICT felt more confident in managing their loved one's pain. This toolkit could improve life for both caregivers and patients by ensuring pain is addressed more quickly and effectively.45678

Who Is on the Research Team?

CA

Catherine A Riffin, PhD

Principal Investigator

Weill Medical College of Cornell University

Are You a Good Fit for This Trial?

This trial is for caregivers over 21 years old who speak English, are cognitively intact, and provide weekly care to someone with dementia or cognitive impairment and chronic pain enrolled in a PACE program. The person with dementia must not be in hospice or have a terminal illness with less than 6 months life expectancy.

Inclusion Criteria

I have been diagnosed with pain.
I visit the person I care for at least once a week.
CAREGIVER PARTICIPANTS: Provides care to a PACE participant
See 12 more

Exclusion Criteria

PATIENT PARTICIPANTS: Unresponsive to environment
I visit the person I care for less than once a week.
CAREGIVER PARTICIPANTS: Does not provide care to a PACE participant
See 13 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the Pain Identification and Communication Toolkit (PICT) intervention, consisting of 4 weekly telephone sessions (30-60 minutes each) delivered by a trained interventionist.

4 weeks
4 visits (telephone)

Follow-up

Participants are monitored for changes in pain management and caregiver self-efficacy at 1, 3, and 6 months post-treatment.

6 months
3 visits (assessment at 1, 3, and 6 months)

What Are the Treatments Tested in This Trial?

Interventions

  • Pain Identification and Communication Toolkit
Trial Overview The study tests the Pain Identification and Communication Toolkit (PICT), designed to help caregivers of people with Alzheimer's disease recognize and communicate about their care recipient's pain through training and coaching.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Pain Identification and Communication ToolkitExperimental Treatment1 Intervention
Group II: Attention ControlPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Weill Medical College of Cornell University

Lead Sponsor

Trials
1,103
Recruited
1,157,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Published Research Related to This Trial

The study evaluated a multi-dimensional tool for assessing pain in cognitively impaired adults, revealing that certain pain indicators were more frequently observed and documented, particularly during morning shifts.
Nurses' compliance in recording pain observations was inconsistent, highlighting the need for better training and support to enhance pain assessment practices, which should combine physiological and behavioral indicators based on clinical judgment.
Pain assessment and cognitive impairment: part 2.Davies, E., Male, M., Reimer, V., et al.[2019]
Accurate pain management in patients with advanced dementia and Alzheimer's Disease requires individualized and ongoing pain assessment, as self-reports may not be possible due to communication difficulties.
The article introduces a scientifically validated pain assessment tool specifically designed for non-verbal patients, emphasizing the importance of recognizing the patient's authority on their pain experience.
A pain assessment tool for people with advanced Alzheimer's and other progressive dementias.Lane, P., Kuntupis, M., MacDonald, S., et al.[2019]
The Pain Assessment in Advanced Dementia (PAINAD) tool was developed and validated for assessing pain in individuals with advanced dementia who cannot communicate their pain, showing good reliability and validity in a study involving 19 residents and expert clinicians.
PAINAD effectively detected changes in pain levels before and after analgesic medication was administered, indicating its potential utility in clinical settings for improving pain management in noncommunicative patients.
Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale.Warden, V., Hurley, AC., Volicer, L.[2022]

Citations

The Pain Identification and Communication ToolkitPROJECT SUMMARY Up to 60% of older persons with Alzheimer's disease and related dementias (ADRD) suffer from bothersome pain and nearly half experience ...
The Pain Identification and Communication ToolkitThe purpose of this study is to compare the efficacy of the Pain Identification and Communication Toolkit (PICT) with a Health Promotion (HP) program.
Evaluating the Efficacy of the Pain Identification and Co...Despite best-practice guidelines calling for routine pain assessment of persons with ADRD, pain is severely under-detected and poorly managed in ...
Pain Communication Toolkit for Caregivers of Alzheimer's ...This study will evaluate the Pain Identification and Communication Toolkit (PICT), a multicomponent intervention for caregivers of people with Alzheimer's ...
The Pain Identification and Communication ToolkitTrial Description: The purpose of this study is to compare the efficacy of the Pain Identification and Communication Toolkit (PICT) with a Health Promotion (HP) ...
The Pain Identification and Communication ToolkitPROJECT SUMMARY Up to 60% of older persons with Alzheimer's disease and related dementias (ADRD) suffer from bothersome pain and nearly half experience pain- ...
Evaluating the Efficacy of the Pain Identification and ...A phase of research to describe clinical trials that gather more information about a drug's safety and effectiveness by studying different ...
Evaluating the Efficacy of the Pain Identification and ...This study will evaluate the Pain Identification and Communication Toolkit (PICT), a multicomponent intervention for caregivers of people with ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security